Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
2.370
+0.030 (1.28%)
At close: May 13, 2025, 4:00 PM
2.380
+0.010 (0.42%)
Pre-market: May 14, 2025, 6:28 AM EDT
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $64.16 million as of May 14, 2025. Its market cap has decreased by -83.10% in one year.
Market Cap
64.16M
Enterprise Value
-87.12M
1-Year Change
-83.10%
Ranking
Category
Stock Price
$2.37
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has decreased from $528.69M to $64.16M, a decrease of -87.86%. That is a compound annual growth rate of -80.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 63.35M | -44.47% |
| Dec 31, 2024 | 114.08M | -78.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.42B |
| Johnson & Johnson | 357.61B |
| AbbVie | 331.89B |
| Novo Nordisk | 292.03B |
| UnitedHealth Group | 290.13B |
| Abbott Laboratories | 225.47B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |